Soligenix, headquartered in New Jersey, collaborates with the University of Hawaiʻi at Mānoa on vaccine development for Sudan and Marburg viruses, holding FDA designations.
2 reports, 2 independent
Updated May 27
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Soligenix, headquartered in New Jersey, collaborates with the University of Hawaiʻi at Mānoa on vaccine development for Sudan and Marburg viruses, holding FDA designations.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
University of Hawaiʻi at Mānoa
public co-educational research university and flagship University of Hawaiʻi system
Nothing else this week.
Coverage
Newest first; wire copies grouped- benzinga.com
- PR NewswireSoligenix Announces Publication Describing Long-Term High Temperature Stability of Protein Subunit Vaccines for Ebola and Related Viruses Two Year Stability demonstrated in both bivalent and trivalen